Venlafaxine in children and adolescents with attention deficit hyperactivity disorder

Psychiatry and Clinical Neurosciences

Volumn 58, Issue 1, 2004, Pages 92-95

  Mukaddes, Nahit Motavalli ^a   Abali, Osman ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Adolescents; Attention deficit hyperactivity disorder; Children; Treatment; Venlafaxine

Indexed keywords

METHYLPHENIDATE; NEUROLEPTIC AGENT; VENLAFAXINE;

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; COMORBIDITY; DEPRESSION; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HEADACHE; HUMAN; MALE; SOMNOLENCE; STOMACH PAIN;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; CYCLOHEXANOLS; FEMALE; HUMANS; MALE; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 1042265340     PISSN: 13231316     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1819.2004.01199.x     Document Type: Article

References (10)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Association, Washington DC, 1994.
2. Biederman J, Baldessarini RJ, Wright V, Knee D, Harmatz JS. A double-blind placebo controlled study of desipramine in the treatment of ADD. I. Efficacy. J. Am. Acad. Child Adolesc. Psychiatry 1989; 28: 777-784.
3. Adler LA, Resnick S, Kunz M, Devinsky O. Open label trial of venlafaxine in adults with attention deficit disorder. Psychopharmacol. Bull. 1995; 31: 785-788.
4. Hedges D, Reimherr FW, Rogers A, Strong R, Wender PH. An open label trial of venlafaxine in adult patients with attention deficit hyperactivity disorder. Psychopharmacol. 1995; 31: 779-783.
5. Findling RL, Schwartz MA, Flannery DJ, Manos MJ. Venlafaxine in adults with attention-deficit hyperactivity disorder: An open clinical trial. J. Clin. Psychiatry 1997; 58: 178-179.
6. Upadhyaya HP, Brady KT, Sethurraman G, Sonne SC, Malcolm R. Venlafaxine treatment of patients with comorbid alcohol/cocain abuse and attention-deficit/hyperactivity disorder: a pilot study. J. Clin. Psychopharmacol. 2001; 21: 116-118.
7. Olvera RL, Pliska SR, Luch J, Tatum R. An open clinical trial of venlafaxine in the treatment of attention-deficit/hyperactivity disorder in children and adolescent. J. Child Adolesc. Psychopharmacol. 1996; 6: 241.
8. Goyette CH, Conners CK, Ulrich RF. Normative data on revised Conners Parent and Teacher Rating Scales. J. Abnorm. Child Psychol. 1978; 6: 221-236.
9. Campbell M, Palij M. Clinical Global Improvement Scale. Psychopharmacol. Bull. 1985; 21: 839-848.
10. Saletu B, Grunberger J, Anderer P, Linzmayer L, Semlitsch HV, Magni G. Pharmacodynamics of venlafaxine evaluated by EEG brain mapping, psychometry and psychophiology. Br. J. Clin. Pharmacol. 1992; 33: 589-601.